Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PAROXETINE EXTENDED RELEASE TABLETS safely and effectively. See full prescribing information for PAROXETINE EXTENDED RELEASE TABLETS. PAROXETINE extended-release tablets, for oral use Initial U.S. Approval: 1992
Medication labelWhy this: Advisory · dailymed-prescription
Paroxetine extended-release tablets USP are indicated in adults for the treatment of: Major depressive disorder (MDD) Panic disorder (PD) Social anxiety disorder (SAD) Premenstrual dysphoric disorder (PMDD)
- generic_name
- paroxetine
- product_names
- PAROXETINE
- ndc
- 68180-645, 68180-646, 68180-647, 68180-647-06, 68180-647-01, 68180-647-02, 68180-647-03, 68180-646-06, 68180-646-01, 68180-646-02, 68180-646-03, 68180-645-06, 68180-645-01, 68180-645-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en